3//SEC Filing
Israel Biotech Fund I, L.P. 3
Accession 0000899243-20-012312
CIK 0001797336other
Filed
May 6, 8:00 PM ET
Accepted
May 7, 7:40 PM ET
Size
10.4 KB
Accession
0000899243-20-012312
Insider Transaction Report
Form 3
Israel Biotech Fund I, L.P.
10% Owner
Holdings
Series B Preferred Stock
→ Common Stock (211,757 underlying)- 2,509,131
Common Stock
Series A Preferred Stock
→ Common Stock (369,231 underlying)
Footnotes (1)
- [F1]The preferred stock is convertible at any time, at the holder's election and has no expiration date. Each share of preferred stock shall be automatically converted into one (1) share of common stock upon the closing of the Issuer's initial public offering.
Issuer
Ayala Pharmaceuticals, Inc.
CIK 0001797336
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001652458
Filing Metadata
- Form type
- 3
- Filed
- May 6, 8:00 PM ET
- Accepted
- May 7, 7:40 PM ET
- Size
- 10.4 KB